Log in
ASX:RHT

Resonance Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.18
MA: A$0.18
A$0.18
52-Week Range N/A
Volume2.57 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow. It also provides imaging core laboratory and support services for clinical trials, including clinical measurement, as well as project and data management services, such as reporting, administration, and support. The company serves clinicians for the diagnosis and management of human diseases; and pharmaceutical companies for their clinical trials. Resonance Health Limited has collaboration with Perth Radiological Clinic for the sharing of data and the training of neural networks to assess the viability of the development of various screening tools. The company is headquartered in Burswood, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 8 9286 5300
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.67 million
Book ValueA$0.02 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableOptionable

Receive RHT News and Ratings via Email

Sign-up to receive the latest news and ratings for RHT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Resonance Health (ASX:RHT) Frequently Asked Questions

Who are some of Resonance Health's key competitors?

What other stocks do shareholders of Resonance Health own?

Who are Resonance Health's key executives?

Resonance Health's management team includes the following people:
  • Ms. Alison Laws, Chief Exec. Officer
  • Mr. Agha Shahzad Pervez B.Sc., CFO & Company Sec.
  • Dr. Timothy Guy St. Pierre, Chief Scientific Officer
  • Ms. Celine Royet, Quality Assurance & Regulatory Affairs Mang.
  • Dr. Jason Loveridge B.Sc, Ph.D., FRSM, Corp. Advisor

What is Resonance Health's stock symbol?

Resonance Health trades on the ASX under the ticker symbol "RHT."

How big of a company is Resonance Health?

Resonance Health has a market capitalization of $0.00 and generates $3.67 million in revenue each year.

What is Resonance Health's official website?

The official website for Resonance Health is www.resonancehealth.com.

How can I contact Resonance Health?

The company can be reached via phone at 61 8 9286 5300.

This page was last updated on 10/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.